1 4 U Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Abatacept, ATC L04AA24 for the period 01092024 - 31082026

Germany, Sept. 4 -- Germany based 1 4 U Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Abatacept, ATC L04AA24 for the period 01092024 - 31082026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....